Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of disease population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time
go back to main search page
Accession:CMO:0001625 term browser browse the term
Definition:The number of new cases of relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE) appearing in a study population of individuals that already have experimental autoimmune encephalomyelitis during a certain period compared to the total number of individuals in that already-diseased study population, expressed as a percentage. R-EAE is an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells where such induction results in a disease characterized by repeated symptomatic attacks followed by complete or almost complete improvement.
Synonyms:related_synonym: incidence of relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE) in a disease population



show annotations for term's descendants           Sort by:

Term paths to the root